:: Boston-Israel Business Forum ::


		The Boston-Israel Business Forum is founded as a non-profit organization with a mission to:
		Provide a forum for American and Israeli professionals in Boston to network in a business context, share ideas and benefit from a high-caliber group of individuals Promote awareness of Israeli economy, industries and potential among the local business community. Allow Israeli businesses to better integrate into the local market via networking as well as sharing challenges and opportunities

Please click on a name below to see more information about the individual.

President: Daniel Poscover, Entrepreneur

Israel Drori, ZIXI

Adam Towvim, JumpTap

President: Daniel Poscover, Entrepreneur, Former Founding Partner at Scientia Advisors

Daniel Poscover is the co-founder of PharmacoGenetics Clinical Advisory Board (PCAB), a health IT firm developing decision support tools and knowledge resources on pharmacogenomics and personalized medicine. PCAB is enabling healthcare payors and pharmacy benefit managers to streamline their decision making and drive more efficacious therapies with fewer side effects.

Dan was a co-founding partner of Scientia Advisors, an international strategy and management consulting firm with a concentration in life sciences. He has a breadth of experiences ranging from strategic consulting to serial entrepreneur to investment analyst. As an entrepreneur, Daniel has been a member of the management teams of several successful emerging companies. He has advised and consulted dozens of both emerging and established life science firms. of both emerging and established life science firms.

Prior to Scientia, Daniel was the Managing Partner of BioStrategy Advisors, a life science strategy consulting firm. His entrepreneur experiences include CombinatoRx (CRXX), Glenveigh Pharmaceuticals, New England OncoTherapeutics and others. He was the VP of Finance at CombinatoRx where he helped grow the firm from startup to 75 employees within Oncology and Inflamation markets. He also served as an investment analyst for FSA, a financial advisory firm which managed a $4.5Bn fund where he focused his analysis on hedge funds and venture capital firms.